摘要 |
<p>The present invention relates to the use of an EP4 receptor agonist and pharmaceutically acceptable derivatives thereof for the manufacture of a medicament for the treatment of neurpathic pain, excluding use of [4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetic acid and pharmaceutically acceptable derivatives thereof.</p> |